Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionHodges Capital Management Inc.
Latest Disclosed Ownership8,718 shares
Latest Disclosed Value $ 1,215,028
Hodges Capital Management Inc. reports 1.70% increase in ownership of GILD / Gilead Sciences, Inc.

On April 28, 2026 - Hodges Capital Management Inc. filed a 13F-HR form disclosing ownership of 8,718 shares of Gilead Sciences, Inc. (CH:GILD) valued at $1,215,028 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 8,572 shares of Gilead Sciences, Inc.. This represents a change in shares of 1.70% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F Gilead Sciences COM 375558103 8,718 146 1.70 1,215 15.49 0.1005
2026-02-11 2025-12-31 13F Gilead Sciences COM 375558103 8,572 -63 -0.73 1,052 9.81 0.0904
2025-11-07 2025-09-30 13F Gilead Sciences COM 375558103 8,635 8,635 958 0.0820
2025-08-07 2025-06-30 13F GILEAD SCIENCES COM 375558103 0 -1,700 -100.00 0 -100.00
2025-06-02 2025-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 1,700 1,700 3,834 0.3824
2025-05-16 2025-03-31 13F GILEAD SCIENCES COM 375558103 2,550 2,550 5,751 0.3716
2019-02-08 2018-12-31 13F Gilead Sciences COM 375558103 0 -4,720 -100.00 0 -100.00
2018-10-29 2018-09-30 13F Gilead Sciences COM 375558103 4,720 -25 -0.53 364 8.33 0.0268
2018-07-26 2018-06-30 13F Gilead Sciences COM 375558103 4,745 -10,160 -68.17 336 -70.11 0.0248
2018-05-03 2018-03-31 13F Gilead Sciences COM 375558103 14,905 -1,928 -11.45 1,124 -6.80 0.0887
2018-02-06 2017-12-31 13F Gilead Sciences COM 375558103 16,833 -23,806 -58.58 1,206 -63.38 0.0884
2017-11-02 2017-09-30 13F Gilead Sciences COM 375558103 40,639 5,893 16.96 3,293 33.92 0.2223
2017-07-31 2017-06-30 13F Gilead Sciences COM 375558103 34,746 9,704 38.75 2,459 44.56 0.1457
2017-05-08 2017-03-31 13F Gilead Sciences COM 375558103 25,042 -16,212 -39.30 1,701 -42.42 0.0849
2017-01-27 2016-12-31 13F Gilead Sciences COM 375558103 41,254 18,876 84.35 2,954 66.80 0.1359
2016-11-10 2016-09-30 13F Gilead Sciences COM 375558103 22,378 -1,272 -5.38 1,771 -10.24 0.0852
2016-08-11 2016-06-30 13F Gilead Sciences COM 375558103 23,650 -1,294 -5.19 1,973 -13.88 0.0958
2016-05-26 2016-03-31 13F Gilead Sciences COM 375558103 24,944 -16,574 -39.92 2,291 -45.47 0.1059
2016-02-10 2015-12-31 13F Gilead Sciences COM 375558103 41,518 23,452 129.81 4,201 136.81 0.1748
2015-11-12 2015-09-30 13F Gilead Sciences COM 375558103 18,066 11,204 163.28 1,774 120.92 0.0727
2015-08-06 2015-06-30 13F Gilead Sciences COM 375558103 6,862 -2,200 -24.28 803 -9.67 0.0292
2015-05-08 2015-03-31 13F Gilead Sciences COM 375558103 9,062 -1,000 -9.94 889 -6.22 0.0339
2015-02-17 2014-12-31 13F Gilead Sciences COM 375558103 10,062 -157,138 -93.98 948 -94.67 0.0386
2014-11-14 2014-09-30 13F Gilead Sciences COM 375558103 167,200 2,220 1.35 17,798 30.12 0.7390
2014-08-15 2014-06-30 13F GILEAD SCIENCES INC COM COM 375558103 164,980 34,932 26.86 13,678 48.43 0.6399
2014-05-07 2014-03-31 13F GILEAD SCIENCES INC COM COM 375558103 130,048 130,048 9,215 0.5424
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.